Rapport Therapeutics (RAPP) Expected to Announce Quarterly Earnings on Thursday

Rapport Therapeutics (NASDAQ:RAPP) is anticipated to issue its quarterly earnings data before the market opens on Thursday, February 27th. Analysts expect the company to announce earnings of ($0.62) per share for the quarter.

Rapport Therapeutics Price Performance

Shares of NASDAQ:RAPP opened at $13.24 on Tuesday. Rapport Therapeutics has a 12 month low of $12.09 and a 12 month high of $29.74. The stock’s 50 day moving average price is $16.00 and its 200 day moving average price is $19.81.

About Rapport Therapeutics

Rapport Therapeutics Inc is a clinical-stage biotechnology company. It focused on discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. Rapport Therapeutics Inc is based in BOSTON.